Philippe Irigaray

1.5k total citations
27 papers, 1.1k citations indexed

About

Philippe Irigaray is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Philippe Irigaray has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 8 papers in Molecular Biology and 8 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Philippe Irigaray's work include Carcinogens and Genotoxicity Assessment (6 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and Adipose Tissue and Metabolism (5 papers). Philippe Irigaray is often cited by papers focused on Carcinogens and Genotoxicity Assessment (6 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and Adipose Tissue and Metabolism (5 papers). Philippe Irigaray collaborates with scholars based in France, Sweden and United Kingdom. Philippe Irigaray's co-authors include D Belpomme, Richard Clapp, Luc Montagnier, J.A. Newby, C. V. Howard, Lennart Hardell, A J Sasco, Slava S. Epstein, Samuel S. Epstein and Lennart Hardell and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Carcinogenesis.

In The Last Decade

Philippe Irigaray

26 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Irigaray France 13 321 223 192 142 113 27 1.1k
Ryszard Andrzejak Poland 20 414 1.3× 185 0.8× 119 0.6× 388 2.7× 115 1.0× 104 1.4k
Francisco Artacho‐Cordón Spain 26 919 2.9× 210 0.9× 264 1.4× 157 1.1× 85 0.8× 65 1.6k
Hubert Dirven Norway 25 954 3.0× 447 2.0× 169 0.9× 122 0.9× 90 0.8× 75 2.1k
Andrew G. Salmon United States 19 300 0.9× 187 0.8× 133 0.7× 193 1.4× 218 1.9× 27 1.1k
Mary Ann Butler United States 20 259 0.8× 443 2.0× 477 2.5× 143 1.0× 54 0.5× 42 1.3k
Ying Han China 22 189 0.6× 369 1.7× 113 0.6× 252 1.8× 44 0.4× 87 1.6k
Ziyuan Zhou China 25 589 1.8× 514 2.3× 176 0.9× 99 0.7× 280 2.5× 76 1.9k
Gary L. Foureman United States 17 343 1.1× 291 1.3× 168 0.9× 77 0.5× 65 0.6× 28 1.0k
D. F. CHURCH United States 7 240 0.7× 496 2.2× 130 0.7× 41 0.3× 303 2.7× 17 1.6k
Mary S. Wolfe United States 15 415 1.3× 131 0.6× 118 0.6× 77 0.5× 65 0.6× 24 1.5k

Countries citing papers authored by Philippe Irigaray

Since Specialization
Citations

This map shows the geographic impact of Philippe Irigaray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Irigaray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Irigaray more than expected).

Fields of papers citing papers by Philippe Irigaray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Irigaray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Irigaray. The network helps show where Philippe Irigaray may publish in the future.

Co-authorship network of co-authors of Philippe Irigaray

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Irigaray. A scholar is included among the top collaborators of Philippe Irigaray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Irigaray. Philippe Irigaray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Belpomme, D, et al.. (2024). Free Methylglyoxal as a Metabolic New Biomarker of Tumor Cell Proliferation in Cancers. Cancers. 16(23). 3922–3922. 1 indexed citations
3.
Belpomme, D & Philippe Irigaray. (2023). Combined Neurological Syndrome in Electrohypersensitivity and Multiple Chemical Sensitivity: A Clinical Study of 2018 Cases. Journal of Clinical Medicine. 12(23). 7421–7421. 2 indexed citations
4.
Belpomme, D & Philippe Irigaray. (2022). Why electrohypersensitivity and related symptoms are caused by non-ionizing man-made electromagnetic fields: An overview and medical assessment. Environmental Research. 212(Pt A). 113374–113374. 14 indexed citations
5.
Belpomme, D & Philippe Irigaray. (2020). Electrohypersensitivity as a Newly Identified and Characterized Neurologic Pathological Disorder: How to Diagnose, Treat, and Prevent It. International Journal of Molecular Sciences. 21(6). 1915–1915. 28 indexed citations
6.
Belpomme, D & Philippe Irigaray. (2016). Replicative random mutations as an unproven cause of cancer: A technical comment. Molecular and Clinical Oncology. 4(4). 497–499. 2 indexed citations
7.
8.
Chiavarina, Barbara, Marie‐Julie Nokin, Florence Durieux, et al.. (2014). Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes. Oncotarget. 5(14). 5472–5482. 46 indexed citations
9.
Irigaray, Philippe, Stéphanie Lacomme, L. Méjean, & D Belpomme. (2009). Ex vivo study of incorporation into adipocytes and lipolysis-inhibition effect of polycyclic aromatic hydrocarbons. Toxicology Letters. 187(1). 35–39. 20 indexed citations
10.
11.
Irigaray, Philippe & D Belpomme. (2009). Basic properties and molecular mechanisms of exogenous chemical carcinogens. Carcinogenesis. 31(2). 135–148. 90 indexed citations
12.
Belpomme, D, Philippe Irigaray, & Lennart Hardell. (2008). Electromagnetic fields as cancer-causing agents. Environmental Research. 107(2). 289–290. 7 indexed citations
13.
Belpomme, D, Philippe Irigaray, Lennart Hardell, et al.. (2007). The multitude and diversity of environmental carcinogens. Environmental Research. 105(3). 414–429. 187 indexed citations
14.
Irigaray, Philippe, J.A. Newby, Richard Clapp, et al.. (2007). Lifestyle-related factors and environmental agents causing cancer: An overview. Biomedicine & Pharmacotherapy. 61(10). 640–658. 239 indexed citations
15.
Belpomme, D, Philippe Irigaray, A J Sasco, et al.. (2007). The growing incidence of cancer: Role of lifestyle and screening detection (Review). International Journal of Oncology. 30(5). 1037–49. 76 indexed citations
16.
Irigaray, Philippe, J.A. Newby, Stéphanie Lacomme, & D Belpomme. (2007). Overweight/obesity and cancer genesis: More than a biological link. Biomedicine & Pharmacotherapy. 61(10). 665–678. 70 indexed citations
17.
Irigaray, Philippe, Richard Clapp, Lennart Hardell, et al.. (2007). Dossier : Cancer : Influence of environment Lifestyle-related factors and environmental agents causing cancer: An overview. 5 indexed citations
18.
Irigaray, Philippe, Virginie Ogier, S. Jacquenet, et al.. (2006). Benzo[a]pyrene impairs β‐adrenergic stimulation of adipose tissue lipolysis and causes weight gain in mice. FEBS Journal. 273(7). 1362–1372. 118 indexed citations
19.
Irigaray, Philippe, Virginie Ogier, S. Jacquenet, et al.. (2006). Benzo[a]pyrene impairs beta-adrenergic stimulation of adipose tissue lipolysis and causes weight gain in mice. A novel molecular mechanism of toxicity for a common food pollutant. HAL (Le Centre pour la Communication Scientifique Directe). 3 indexed citations
20.
Irigaray, Philippe, et al.. (2005). Behaviour of dioxin in pig adipocytes. Food and Chemical Toxicology. 43(3). 457–460. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryszard Andrzejak Breakdown of academic impact, for papers by Francisco Artacho‐Cordón Breakdown of academic impact, for papers by Hubert Dirven Breakdown of academic impact, for papers by Andrew G. Salmon Breakdown of academic impact, for papers by Mary Ann Butler Breakdown of academic impact, for papers by Ying Han Breakdown of academic impact, for papers by Ziyuan Zhou Breakdown of academic impact, for papers by Gary L. Foureman Breakdown of academic impact, for papers by D. F. CHURCH Breakdown of academic impact, for papers by Mary S. Wolfe
Rankless by CCL
2026